The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat
- 6 February 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 273 (3), 273-279
- https://doi.org/10.1016/0014-2999(94)00698-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Contribution of serotonin neurotoxins to understanding psychiatric disordersInternational Clinical Psychopharmacology, 1993
- Ritanserin, a Selective 5-HT2/1C Antagonist, and Negative Symptoms in SchizophreniaThe British Journal of Psychiatry, 1993
- Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivoNeuroscience Letters, 1993
- Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental areaJournal of Comparative Neurology, 1992
- Excitatory responses to serotonin (5‐HT) in neurons of the rat piriform cortex: Evidence for mediation by 5‐HT1C receptors in pyramidal cells and 5‐HT2 receptors in interneuronsSynapse, 1991
- Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis StudyJournal of Neurochemistry, 1990
- Recall memory deficit in schizophrenia: A possible manifestation of prefrontal dysfunctionSchizophrenia Research, 1989
- Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin‐S2 receptor blockerDrug Development Research, 1986
- Mescaline‐induced head‐twitches in the rat: An in vivo method to evaluate serotonin S2 antagonistsDrug Development Research, 1983
- Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in ratsNature, 1980